AGIO (STOCKS)
Agios Pharmaceuticals, Inc.
$32.663000
+3.203000 (+10.87%)
Prev close: $29.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Brian M. Goff
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,892.98M
- Employees
- 488
- P/E (TTM)
- -4.06
- P/B (TTM)
- 1.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
7
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.69 | $-1.84 | +0.1467 | +7.99% |
|
Dec 2025 (Q4)
|
$-1.86 | $-1.99 | +0.1252 | +6.31% |
|
Sep 2025 (Q3)
|
$-1.78 | $-1.94 | +0.1567 | +8.09% |
|
Jun 2025 (Q2)
|
$-1.93 | $-1.84 | -0.0863 | -4.68% |
Financial Statements
| Revenues | $66.05M |
| Benefits Costs and Expenses | $515.62M |
| Cost Of Revenue | $6.58M |
| Costs And Expenses | $541.58M |
| Gross Profit | $59.47M |
| Operating Expenses | $535.00M |
| Selling, General, and Administrative Expenses | $187.06M |
| Research and Development | $347.94M |
| Operating Income/Loss | -$475.53M |
| Income/Loss From Continuing Operations After Tax | -$422.60M |
| Income/Loss From Continuing Operations Before Tax | -$434.53M |
| Net Income/Loss | -$422.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$422.60M |
| Net Income/Loss Available To Common Stockholders, Basic | -$422.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.25 |
| Diluted Earnings Per Share | -$7.25 |
| Basic Average Shares | 174,979,925 |
| Diluted Average Shares | 174,979,925 |
| Assets | $1.18B |
| Current Assets | $834.84M |
| Cash | $1.00B |
| Inventory | $35.09M |
| Noncurrent Assets | $350.15M |
| Fixed Assets | $10.57M |
| Other Non-current Assets | $339.58M |
| Liabilities | $75.88M |
| Current Liabilities | $58.85M |
| Accounts Payable | $13.75M |
| Wages | $11.69M |
| Other Current Liabilities | $33.41M |
| Noncurrent Liabilities | $17.03M |
| Equity | $1.11B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.11B |
| Liabilities And Equity | $1.18B |
| Net Cash Flow From Operating Activities | -$380.41M |
| Net Cash Flow From Operating Activities, Continuing | -$380.41M |
| Net Cash Flow From Investing Activities | $405.91M |
| Net Cash Flow From Investing Activities, Continuing | $405.91M |
| Net Cash Flow From Financing Activities | $9.14M |
| Net Cash Flow From Financing Activities, Continuing | $9.14M |
| Net Cash Flow | $34.64M |
| Net Cash Flow, Continuing | $34.64M |
| Comprehensive Income/Loss | -$423.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$423.28M |
| Other Comprehensive Income/Loss | -$311.55M |